Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Inventory (2016 - 2025)

Historic Inventory for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $32.3 million.

  • Lifecore Biomedical, Inc. \De\'s Inventory fell 1923.01% to $32.3 million in Q2 2025 from the same period last year, while for May 2025 it was $32.3 million, marking a year-over-year decrease of 1923.01%. This contributed to the annual value of $32.3 million for FY2025, which is 1923.01% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Inventory amounted to $32.3 million in Q2 2025, which was down 1923.01% from $34.6 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Inventory's 5-year high stood at $42.0 million during Q1 2023, with a 5-year trough of $31.4 million in Q1 2021.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Inventory value was $38.8 million (recorded in 2022), while the average stood at $37.8 million.
  • Examining YoY changes over the last 5 years, Lifecore Biomedical, Inc. \De\'s Inventory showed a top increase of 2753.47% in 2021 and a maximum decrease of 5311.44% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Inventory (Quarter) stood at $39.7 million in 2021, then dropped by 3.26% to $38.4 million in 2022, then grew by 7.88% to $41.4 million in 2023, then fell by 5.39% to $39.2 million in 2024, then decreased by 17.65% to $32.3 million in 2025.
  • Its last three reported values are $32.3 million in Q2 2025, $34.6 million for Q1 2025, and $39.2 million during Q4 2024.